Biotest AG (BIESF)
PNK: BIESF
· Real-Time Price · USD
32.00
0.00 (0.00%)
At close: Apr 30, 2025, 8:00 PM
0.00% (1D)
| Bid | 31.36 |
| Market Cap | 1.63B |
| Revenue (ttm) | 726.2M |
| Net Income (ttm) | 26.4M |
| EPS (ttm) | 0.75 |
| PE Ratio (ttm) | 42.67 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 36.36 |
| Volume | 100 |
| Avg. Volume (20D) | 1 |
| Open | 32.00 |
| Previous Close | 32.00 |
| Day's Range | 32.00 - 32.00 |
| 52-Week Range | 30.48 - 32.00 |
| Beta | 0.15 |
About BIESF
Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophyl...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 9, 2014
Employees 2,495
Stock Exchange PNK
Ticker Symbol BIESF
Website https://www.biotest.com